Dan Chevallard

Chief Financial & Accounting Officer at Regulus Therapeutics, Inc.

Dan Chevallard

Dan Chevallard

Chief Financial & Accounting Officer at Regulus Therapeutics, Inc.

Biography

Dan Chevallard

Dan Chevallard joined Regulus in December 2012 as Vice President, Accounting and Financial Reporting, became our Vice President, Finance and Accounting in May 2013 and was appointed to the role of Chief Financial Officer in May 2017. Prior to joining Regulus, Mr. Chevallard held various senior roles in corporate finance, accounting and financial reporting including Controller and Senior Director, Finance of Prometheus Laboratories Inc. (acquired by Nestle´ Health Science in July 2011). Prior to joining Prometheus, Mr. Chevallard spent approximately five years in public accounting at Ernst & Young, LLP in their assurance services practice. He received his Bachelor of Accountancy from the University of San Diego and is a Certified Public Accountant in the state of California.

Overview
Career Highlights

Regulus Therapeutics, Inc.

RelSci Relationships

105

Birthday

1980

Age

38

Contact Data
Trying to get in touch with Dan Chevallard? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Dan Chevallard likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Regulus Therapeutics, Inc.

Relationship likelihood: Strong

Chief Research & Development Officer at Regulus Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer at AmpliPhi Biosciences Corp.

Relationship likelihood: Strong

Founder at SENTÉ, Inc. (California)

Relationship likelihood: Strong

Leader at Regulus Therapeutics, Inc.

Relationship likelihood: Strong

Science Partner at The Column Group LLC

Relationship likelihood: Average

Advisor at IIF Management Co. LLC

Relationship likelihood: Average

Co-Founder at Exelixis, Inc.

Relationship likelihood: Average

Associate Director, CMC Analytical Development at Regulus Therapeutics, Inc.

Relationship likelihood: Average

Senior Vice President, Human Capital at Regulus Therapeutics, Inc.

Relationship likelihood: Average

Paths to Dan Chevallard
Potential Connections via
Relationship Science
You
Dan Chevallard
Chief Financial & Accounting Officer at Regulus Therapeutics, Inc.
Education

The University of San Diego (USD) is a private Roman Catholic university in San Diego, California. The university offers 40 baccalaureate degrees, and several degrees in law, nursing, (masters, PhD, and DNP),and other doctorate programs. The university comprises seven different academic colleges.

Career History
Chief Financial & Accounting Officer
Current

Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug product candidates in renal, hepatic, and central nervous systems diseases. The company was founded in September 2007 and is headquartered in San Diego, CA.

Controller & Senior Director-Finance
Prior

Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Dan Chevallard is affiliated with Regulus Therapeutics, Inc., Prometheus Laboratories, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dan Chevallard. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dan Chevallard's profile does not indicate a business or promotional relationship of any kind between RelSci and Dan Chevallard.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/dan-chevallard-114698611
  • https://relationshipscience.com/person/dan-chevallard-114698611